Respiratory Syncytial Virus–Associated Hospitalizations in Children Under Five in Erbil City, Iraq: A Cross-Sectional Study
DOI:
https://doi.org/10.23918/eajse.v11i2p17Keywords:
RSV, ARTI, Pediatrics, Rapid detection, BronchiolitisAbstract
Respiratory syncytial virus (RSV) is a predominant etiological agent of acute respiratory tract infections (ARTI) in young children associated with elevated hospitalization rates. Rapid detection of the virus decreases serious complications. This study was conducted to investigate the incidence of RSV infection in pediatric patients and related demographic and clinical criteria through rapid RSV antigen detection in Erbil city/Iraq. A cross-sectional study performed within the 1st of December 2024, to the 28th of February 2025. It involved 177 children under 5 years who presented with signs of ARTI and visited Raparin Teaching Hospital for children in Erbil city. Nasopharyngeal specimens were collected and tested for RSV antigen using the Combo rapid test (Biotech, China). Approximately 72.4% of RSV-positive patients were hospitalized, with bronchiolitis being the most common clinical diagnosis. RSV infection was significantly higher in infants ≤6 months (53.3%, p<0.001). Higher rates of RSV infection were recorded in infants with artificial feeding (51.7%) and delivered by cesarean section (63.8%). Dyspnea was a significant sign in RSV-associated hospitalizations (p=0.002). RSV infection peaked in January despite higher ARTI rates in December (p<0.01). RSV was a leading winter pathogen in young children with high hospitalization rates. The Combo rapid test offered a quick, cost-effective tool for multi-virus detection.
References
[1] Wang X, Li Y, Shi T, Bont LJ, Chu HY, Zar HJ, et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. 2024. 403(10433): p. 1241-1253. https://doi.org/10.1016/S0140-6736(24)00138-7
[2] Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DWJCDoSR. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. 2014(9). https://doi.org/10.1002/14651858.CD006452
[3] Mahony, J.B., A. Petrich, and M.J.C.r.i.c.l.s. Smieja, Molecular diagnosis of respiratory virus infections. 2011. 48(5-6): p. 217-249. https://doi.org/10.3109/10408363.2011.640976
[4] Aljabali AA, Obeid MA, El-Tanani M, Tambuwala MMJFV.Respiratory syncytial virus: an overview. 2023. 18(9): p. 595-609.
[5] Umar S, Yang R, Wang X, Liu Y, Ke P, Qin SJVj. Molecular epidemiology and characteristics of respiratory syncytial virus among hospitalized children in Guangzhou, China. 2023. 20(1): p. 272. https://doi.org/10.1186/s12985-023-02227-4.
[6] Feng Q, Wang J, Wang X, Tian J, Zhang L, Dilmurat D, Liu M, Ai J, Feng G, Zeng Y, Wang R. Clinical epidemiological characteristics of hospitalized pediatric viral community-acquired pneumonia in China. Journal of Infection. 2025 Mar 1;90(3):106450. https://doi.org/10.2217/fvl-2023-0037
[7] Fitzpatrick T, Buchan SA, Mahant S, Fu L, Kwong JC, Stukel TA, et al. Pediatric respiratory syncytial virus hospitalizations, 2017-2023. 2024. 7(6): p. e2416077-e2416077. https://doi.org/10.1001/jamanetworkopen.2024.16077
[8] Ameen Ghareeb A, Moffaq Abdulaziz S. Clinical & Laboratory markers as predictors for severity and mortality in COVID-19. Polytechnic Journal. 2023 Sep 20;13(1):66-73.https://doi.org/10.59341/2707-7799.1746
[9] Foley DA, Minney-Smith CA, Lee WH, Oakes DB, Hazelton B, Ford TJ, et al. Respiratory syncytial virus reinfections in children in Western Australia. 2023. 15(12): p. 2417. https://doi.org/10.3390/v15122417
[10] Li S, Mei C, Chen S, Wang C, Gao Y, Ma J, Zhong L, Luo T, Zhao X, Bu H, Lyu Y. Protective or limited? Maternal antibodies and RSV-associated lower respiratory tract infection in hospitalized infants aged 28-90 days. Frontiers in Immunology. 2025 Jan 7;15:1437616.https://doi.org/10.3389/fimmu.2024.1437616
[11] Sricharoenchai S, Palla E, Sanicas M. Seasonality of respiratory syncytial viruslower respiratory tract infection (RSV-LRTI) in children in developing countries. J Hum Virol Retrovirol. 2016;3(1):00076.
[12] Abdul-Aziz ZM, Ahmed AE, Hasan MD. Impact of Maternal Education, Feeding Practices, and Clinical Symptoms on Duration of Lower Respiratory Tract Infections in Infants and Young Children. Scientific Research Journal of Medical Sciences. 2024 Jul 10;4:1-0.
[13] Odisho SM, Al-Bana AS, Yaassen NY. Detection of Respiratory syncytial virus infection in a sample of infants in Iraq. Iraqi Journal of Medical Sciences. 2009 Dec 1;7(4).
[14] Al-Shuwaikh AM, Ali SH, Arif HS. 11. DETECTION OF RESPIRATORY SYNCYTIAL VIRUS IN INFANTS AND YOUNG CHILDREN WITH CHEST INFECTION: A COMPARISON OF REVERSE TRANSCRIPTION-PCR TECHNIQUE TO CHROMATOGRAPHIC IMMUNOASSAY AND ENZYME LINKED IMMUNOSORBENT ASSAY. Iraqi Journal of Medical Sciences. 2018 Nov 18;16(3).
[15] Al-Marzoqi AH. Respiratory syncytial virus infection among children under 2 years old in Hillah city, Iraq. Methods. 2013 Nov 27;3(3).
[16] Suryadevara M, Domachowske JB. Epidemiology and seasonality of childhood respiratory syncytial virus infections in the tropics. Viruses. 2021 Apr 16;13(4):696. https://doi.org/10.3390/v13040696.
[17] Gea-Izquierdo E, Gil-Prieto R, Hernández-Barrera V, Gil-de-Miguel ÁJHV, Immunotherapeutics. Respiratory syncytial virus-associated hospitalization in children aged< 2 years in Spain from 2018 to 2021. 2023. 19(2): p. 2231818. https://doi.org/10.1080/21645515.2023.2231818
[18] Halabi KC, Saiman L, Zachariah P. The epidemiology of respiratory syncytial virus in New York City during the coronavirus disease-2019 pandemic compared with previous years. The Journal of Pediatrics. 2022 Mar 1;242:242-4. https://doi.org/10.1016/j.jpeds.2021.10.057
[19] Kim S, Williams TC, Viboud C, Campbell H, Chen J, Spiro DJJV.RSV genomic diversity and the development of a globally effective RSV intervention. 2021. 39(21): p. 2811-2820. https://doi.org/10.1016/j.vaccine.2021.03.096
[20] Naeem R, Albayati H, Insaaf AJJoPT, Pharmacology C. Molecular Detection of Respiratory Syncytial Virus in Infants and Young Children by the Conventional Reverse Transcriptase Polymerase Chain Reaction. 2023. 30(3): p. 1-10.
[21] Pickles RJ, DeVincenzo JP. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. The Journal of pathology. 2015 Jan;235(2):266-76.https://doi.org/10.1002/path.4462
[22] Kombe IK, Agoti CN, Munywoki PK, Baguelin M, Nokes DJ, Medley GFJSr. Integrating epidemiological and genetic data with different sampling intensities into a dynamic model of respiratory syncytial virus transmission. 2021. 11(1): p. 1463. https://doi.org/10.1038/s41598-021-81078
[23] Li L, Ni YA, Song Z, Yi Z, Wang FJBp. Identification of pathogenic genes and transcription factors in respiratory syncytial virus. 2021. 21: p. 1-10. https://doi.org/10.1186/s12887-020-02480-4
[24] Nikfar R, Shamsizadeh A, MAKVANDI M, Khoshghalb A. Detection of respiratory syncytial virus in hospitalized children with acute lower respiratory tract infections, using RT PCR in Ahvaz, Iran. 2013. ; https://doi.org/10.5812/pedinfect.9987
[25] Sangaré L, Curtis MP, Ahmad S. Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography. The Journal of pediatrics. 2006 Sep 1;149(3):373-7. https://doi.org/10.1016/j.jpeds.2006.04.063
[26] Lumley SF, Richens N, Lees E, Cregan J, Kalimeris E, Oakley S, et al. Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic. 2022. 84(1): p. 40-47. https://doi.org/10.1016/j.jinf.2021.10.022
[27] Wilawan Chaiut , Ratana Sapbamrer , Sauwaluk Dacha , Tavitiya Sudjaritruk ,Rungnapa Malasao . Epidemiology and associated factors for hospitalization related respiratory syncytial virus infection among children less than 5 years of age in Northern Thailand. 2023. 16(10): p. 1659-1665. https://doi.org/10.1016/j.jiph.2023.08.004
[28] Tromp I, Kiefte-de Jong J, Raat H, Jaddoe V, Franco O, Hofman A, et al. Breastfeeding and the risk of respiratory tract infections after infancy: The Generation R Study. 2017. 12(2): p. e0172763. https://doi.org/10.1371/journal.pone.0172763
[29] Lamberti LM, Zakarija-Grković I, Fischer Walker CL, Theodoratou E, Nair H, Campbell H, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. 2013. 13: p. 1-8.
[30] Alterman N, Kurinczuk JJ, Quigley MA. Caesarean section and severe upper and lower respiratory tract infections during infancy: Evidence from two UK cohorts. PLoS One. 2021 Feb 16;16(2):e0246832. https://doi.org/10.1371/journal.pone.0246832
[31] Macaubas C, De Klerk N, Holt B, Wee C, Kendall G, Firth M, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. 2003. 362(9391): p. 1192-1197.
[32] Zhang G, Rowe J, Kusel M, Bosco A, McKenna K, De Klerk N, et al. Interleukin-10/interleukin-5 responses at birth predict risk for respiratory infections in children with atopic family history. 2009. 179(3): p. 205-211. https://doi.org/10.1164/rccm.200803-438OC
[33] Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. 2010. 51(1): p. 77-84. https://doi.org/10.1097/MPG.0b013e3181d1b11e
[34] Huurre A, Kalliomäki M, Rautava S, Rinne M, Salminen S, Isolauri EJN. Mode of delivery–effects on gut microbiota and humoral immunity. 2008. 93(4): p. 236-240. https://doi.org/10.1159/000111102
[35] Garcia MCS, Yee AL, Gilbert JA, Dsouza MJAoN, Metabolism. Dysbiosis in children born by caesarean section. 2018. 73: p. 24-32. https://doi.org/10.1159/000492168
[36] Chen, X. and Y.J.M.M. Shi, Determinants of microbial colonization in the premature gut. 2023. 29(1): p. 90.https://doi.org/10.1186/s10020-023-00689-4
[37] Phillips-Farfán B, Gómez-Chávez F, Medina-Torres EA, Vargas-Villavicencio JA, Carvajal-Aguilera K, Camacho LJIJoMS. Microbiota signals during the neonatal period forge life-long immune responses. 2021. 22(15): p. 8162. https://doi.org/10.3390/ijms22158162
[38] Bozzola E, Ciarlitto C, Guolo S, Brusco C, Cerone G, Antilici L, et al.Respiratory syncytial virus bronchiolitis in infancy: the acute hospitalization cost. 2021. 8: p. 594898. https://doi.org/10.3389/fped.2020.594898
[39] Djelantik I, Gessner BD, Soewignjo S, Steinhoff M, Sutanto A, Widjaya A, et al. Incidence and clinical features of hospitalization because of respiratory syncytial virus lower respiratory illness among children less than two years of age in a rural Asian setting. 2003. 22(2): p. 150-156. https://doi.org/10.1097/01.inf.0000048908.43063.c6
[40] Madhi SA, Venter M, Alexandra R, Lewis H, Kara Y, Karshagen WF, et al. Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa. 2003. 27(2): p. 180-189. https://doi.org/10.1016/S1386-6532(02)00174-9
[41] Weber MW, Milligan P, Sanneh M, Awemoyi A, Dakour R, Schneider G, et al.An epidemiological study of RSV infection in the Gambia. 2002. 80(7): p. 562-568.
[42] Fry AM, Chittaganpitch M, Baggett HC, Peret TC, Dare RK, Sawatwong P, et al. The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand. 2010. 5(11): p. e15098. https://doi.org/10.1371/journal.pone.0015098
[43] Xu B, Wang J, Li Z, Xu C, Liao Y, Hu M, et al. Seasonal association between viral causes of hospitalised acute lower respiratory infections and meteorological factors in China: a retrospective study. 2021. 5(3): p. e154-e163.
Downloads
Published
Data Availability Statement
The data supporting the findings of this study are available from the corresponding author upon reasonable request.
License
Copyright (c) 2025 Aumed Jalil, Sazan Moffaq Abdulaziz
This work is licensed under a Creative Commons Attribution 4.0 International License.
Eurasian J. Sci. Eng is distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY-4.0) https://creativecommons.org/licenses/by/4.0/
